Suchergebnisse - "Edelman, Martin J"

PubPharm (315)

1

American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung Cancer

enthalten in: JAMA oncology | 2024

von Rodrigues, G. | Higgins, K. | Rimner, A. | +12

2

Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort

enthalten in: Investigational new drugs | 2024

von Emiloju, O. | Yin, J. | Koubek, E. | +19

3

Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort

enthalten in: Investigational new drugs | 2024

von Emiloju, O. | Yin, J. | Koubek, E. | +19

4

"Cancer's a demon" : a qualitative study of fear and multilevel factors contributing to cancer treatment delays

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2023

von Frosch, Z. | Jacobs, L. | O'Brien, C. | +8

5

Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing

enthalten in: International journal of molecular sciences | 2023

von Fernandez, S. | Tan, Y. | Rao, S. | +13

6

Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP)

enthalten in: JCO precision oncology | 2023

von Vaidya, R. | Unger, J. | Qian, L. | +17

7

Development of a Multilevel Model to Identify Patients at Risk for Delay in Starting Cancer Treatment

enthalten in: JAMA network open | 2023

von Frosch, Z. | Hasler, J. | Handorf, E. | +7

8

American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma

enthalten in: JAMA oncology | 2023

von Chun, S. | Rimner, A. | Amini, A. | +13

9

Monitoring PD-L1 Expression on Circulating Tumor-Associated Cells in Recurrent Metastatic Non-Small-Cell Lung Carcinoma Predicts Response to Immunotherapy With Radiation Therapy

enthalten in: JCO precision oncology | 2022

von Moran, J. | Adams, D. | Edelman, M. | +8

10

Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2022

von Edelman, M. | Dvorkin, M. | Laktionov, K. | +20

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]